Agile Therapeutics reported -15774000 in Operating Profit for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Aceto ACET:US -13710000 2.88M
Adma Biologics ADMA:US $ -14.44M 1.14M
Agile Therapeutics AGRX:US -15774000 877K
Bayer BAYN:GR 530M 2.81B
Biodelivery Sciences International BDSI:US $ 15.62M 4.25M
Biomarin Pharmaceutical BMRN:US $ -53.22M 64.89M
JAZZ PHA JAZZ:US $ 28.37M 97.96M
Johnson & Johnson JNJ:US $ 3849M 2813M
Merk MRK:US $ 4826M 3212M
Pacira Pharmaceuticals PCRX:US $ 31.43M 3.41M
Pain Therapeutics PTIE:US $ -9753000 4.62M
Pfizer PFE:US $ 7647M 1733M
Teva Pharmaceutical Industries TEVA:US $ 623M 41M
Therapeuticsmd TXMD:US -39921000 4.74M